日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Early treatment outcome prediction in metastatic castration-resistant prostate cancer utilizing 3-month tumor growth rate (g-rate) based machine learning model

利用基于3个月肿瘤生长率(g-rate)的机器学习模型预测转移性去势抵抗性前列腺癌的早期治疗结果

Ugwueke, Esther C; Azzam, Mohamed; Zhou, Mengxi; Teply, Benjamin A; Bergan, Raymond C; Wan, Shibiao; Fojo, Antonio Tito; Leuva, Harshraj; Wang, Jieqiong

Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial

急性早幼粒细胞白血病和早期死亡率的学术界合作:ECOG-ACRIN EA9131试验

Jillella, Anand P; Lee, Sandra J; Altman, Jessica K; Luger, Selina M; Tallman, Martin S; Foran, James M; Bradshaw, Danielle; Law, Lisa Y; Bryan, Locke J; Abou Zahr, Abdallah; Begna, Kebede H; Perl, Alexander E; Vadakara, Joseph J L; Qamar, Rubina; Bergan, Raymond C; Fisch, Michael J; Carlos, Ruth C; Wagner, Lynne I; Kota, Vamsi K; Litzow, Mark R

FDA Approval Summary: Belzutifan for VHL Disease Tumors-Letter

FDA批准摘要:Belzutifan用于治疗VHL病肿瘤——信函

Trinh, Jonathan Q; Ellithi, Moataz; Shonka, Nicole; Bergan, Raymond C

Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings

癌症相关巨噬细胞样细胞在非转移性和转移性前列腺癌中均具有预后价值。

Gironda, Daniel J; Bergan, Raymond C; Alpaugh, R Katherine; Danila, Daniel C; Chuang, Tuan L; Hurtado, Brenda Y; Ho, Thai; Adams, Daniel L

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment

吸入伊洛前列素预防肺癌的Ib期试验,并评估其预测和疗效生物标志物

Miller, York E; Ghosh, Moumita; Merrick, Daniel T; Kubala, Brandi; Szabo, Eva; Bengtson, Lisa; Kocherginsky, Masha; Helenowski, Irene B; Benante, Kelly; Schering, Tia; Kim, Jihye; Kim, Hyunmin; Ha, Duc; Bergan, Raymond C; Khan, Seema A; Keith, Robert L

Comparison of sequential versus concurrent chemoradiation regimens in non-metastatic muscle-invasive bladder cancer

非转移性肌层浸润性膀胱癌序贯放化疗与同步放化疗方案的比较

Vieira, Heidi M; Kasper, David P; Wang, Runqiu; Smith, Lynette M; Enke, Charles A; Bergan, Raymond C; Teply, Benjamin A; Baine, Michael J

Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer

循环肿瘤相关巨噬细胞中的微核可预测晚期结直肠癌的进展

Kasabwala, Dimpal M; Bergan, Raymond C; Gardner, Kirby P; Lapidus, Rena; Tsai, Susan; Aldakkak, Mohammed; Adams, Daniel L

Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics

通过连续活检和综合分析来表征晚期乳腺癌的异质性和治疗耐药性。

Li, Allen; Keck, Jamie M; Parmar, Swapnil; Patterson, Janice; Labrie, Marilyne; Creason, Allison L; Johnson, Brett E; Downey, Molly; Thomas, George; Beadling, Carol; Heiser, Laura M; Kolodzie, Annette; Guimaraes, Alexander R; Corless, Christopher L; Gray, Joe W; Mills, Gordon B; Bergan, Raymond C; Mitri, Zahi I

A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

一项针对接受恩扎卢胺单药治疗后病情进展的转移性去势抵抗性前列腺癌男性患者的II期单臂研究,评估帕博利珠单抗联合恩扎卢胺的疗效。

Graff, Julie N; Beer, Tomasz M; Alumkal, Joshi J; Slottke, Rachel E; Redmond, William L; Thomas, George V; Thompson, Reid F; Wood, Mary A; Koguchi, Yoshinobu; Chen, Yiyi; Latour, Emile; Bergan, Raymond C; Drake, Charles G; Moran, Amy E

Clinical trial design: Past, present, and future in the context of big data and precision medicine

临床试验设计:大数据和精准医学背景下的过去、现在和未来

Li, Allen; Bergan, Raymond C